China's Sinopharm says coronavirus vaccine could be ready by year-end: state media - (This is Money via NewsPoints Desk)

  • A COVID-19 vaccine candidate developed by Sinopharm could be ready for public use by the end of this year, according to state media, ahead of a previous expectation it may become available in 2021, as reported in This is Money.

  • Sinopharm Chairman Liu Jingzhen said the company anticipates completing late-stage clinical testing within about three months.

  • Sinopharm's China National Biotec Group unit, which is responsible for two coronavirus vaccine projects, said last month that the vaccine may not be ready until at least 2021 as a lack of new infections in China made it difficult to find people to test it on.

  • Sinopharm's experimental vaccine has entered a Phase III trial involving around 15,000 participants and two vaccine strains in the United Arab Emirates.

To read more NewsPoints articles, click here.